治験管理システム(CTMS)の世界市場2017-2021

◆英語タイトル:Global Clinical Trial Management System (CTMS) Market 2017-2021
◆発行会社/調査会社:Technavio
◆商品コード:IRTNTR15300
◆発行日:2017年11月6日
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆ページ数:84
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[治験管理システム(CTMS)の世界市場2017-2021]についてメールでお問い合わせはこちら
Technavio社が発行した当調査レポートでは、治験管理システム(CTMS)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、治験管理システム(CTMS)の世界市場規模及び予測、需要先別分析、地域別分析/市場規模、主要国別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社は治験管理システム(CTMS)の世界市場が2017-2021年期間中に年平均12.98%成長すると予測しています。当レポート上に記載されている主な企業は、Bioclinica、Medidata、Oracle、PAREXEL等です。
*** レポート概要(サマリー)***

About Clinical Trial Management System (CTMS)
Clinical trials are defined as research studies undertaken to successfully test a drug or a medical device before launching the product in the market. These studies are pivotal as the data generated in these studies forms the basis for the approval process of a drug or a medical device. Typically, these clinical trials are divided into five phases with each phase as critical as any other. It takes approximately 12 years to successfully complete a clinical trial, and the typical cost estimate of a clinical trial is $800 million to $1.2 billion with a success rate of 12% that the drug will get approved in the market or not.

Technavio’s analysts forecast the global clinical trial management system (CTMS) market to grow at a CAGR of 12.98% during the period 2017-2021 .

[Covered in this report]
The report covers the present scenario and the growth prospects of the global clinical trial management system (CTMS) market for 2017-2021 . To calculate the market size, the report considers the revenue generated from the retail sales of CTMS components that comprise software and services.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Clinical Trial Management System (CTMS) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Bioclinica
• Medidata
• Oracle
• PAREXEL

[Other prominent vendors]
• ArisGlobal
• Bio-Optronics
• DATATRAK
• DSG
• ERT Clinical
• FORTE
• MedNet Solutions
• Merge
• Trial By Fire Solutions
• Veeva Systems

[Market driver]
• Increase in R&D expenditure
• For a full, detailed list, view our report

[Market challenge]
• Rising cost of clinical trials
• For a full, detailed list, view our report

[Market trend]
• Increasing outsourcing of clinical trial process
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

*** レポート目次(コンテンツ)***

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
• Market outline

PART 05: MARKET LANDSCAPE
• Market size and forecast
• Five forces analysis

PART 06: MARKET SEGMENTATION BY END-USERS
• Global CTMS market by end-users
• Global CTMS market by pharmaceutical and biotechnology companies
• Global CTMS market by CROs
• Global CTMS market by others

PART 07: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast
• EMEA – Market size and forecast
• APAC – Market size and forecast
• Key leading countries
• Market opportunity

PART 08: DECISION FRAMEWORK

PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 10: MARKET TRENDS
• Increasing outsourcing of clinical trial process
• Integration of CTMS with other systems
• Adoption of cloud computing

PART 11: VENDOR LANDSCAPE
• Competitive scenario
• Investment opportunity

PART 12: KEY VENDOR ANALYSIS
• Bioclinica
• Medidata
• Oracle
• PAREXEL
• Other prominent vendors

PART 13: APPENDIX
• List of abbreviations

[List of Exhibits] 
Exhibit 01: Various phases in a clinical trial
Exhibit 02: Advantage of CTMS
Exhibit 03: Global CTMS market: Market overview
Exhibit 04: Global CTMS market 2016-2021 ($ millions)
Exhibit 05: Factors impacting the global CTMS market
Exhibit 06: Five forces analysis
Exhibit 07: Global CTMS market by end-users 2016-2021 (% share)
Exhibit 08: Global CTMS market by end-users: Snapshot
Exhibit 09: Global CTMS market by pharmaceutical and biotechnology companies 2016-2021 ($ millions)
Exhibit 10: Global CTMS market by CROs 2016-2021 ($ millions)
Exhibit 11: Advantage of using CTMS in retrieving data from CROs
Exhibit 12: Leading CROs with internally developed CTMS systems
Exhibit 13: Global CTMS market by others 2016-2021 ($ millions)
Exhibit 14: Global CTMS market by geography 2016-2021 (% share)
Exhibit 15: Regional comparison
Exhibit 16: Americas – Market size and forecast 2016-2021 ($ millions)
Exhibit 17: Americas – Year-over-year growth
Exhibit 18: EMEA – Market size and forecast 2016-2021 ($ millions)
Exhibit 19: EMEA – Year-over-year growth
Exhibit 20: APAC – Market size and forecast 2016-2021 ($ millions)
Exhibit 21: APAC – Year-over-year growth
Exhibit 22: Key leading countries
Exhibit 23: Strategic success factors for vendors
Exhibit 24: Investment opportunity mapping
Exhibit 25: Bioclinica: Profile
Exhibit 26: Bioclinica: Strength analysis
Exhibit 27: Bioclinica: Strategy assessment
Exhibit 28: Bioclinica: Opportunity assessment
Exhibit 29: Medidata: Profile
Exhibit 30: Medidata: Strength analysis
Exhibit 31: Medidata strategy assessment
Exhibit 32: Medidata: Opportunity assessment
Exhibit 33: Oracle: Profile
Exhibit 34: Oracle: Strength analysis
Exhibit 35: Oracle: Strategy assessment
Exhibit 36: Oracle: Opportunity assessment
Exhibit 37: PAREXEL: Profile
Exhibit 38: PAREXEL: Strength analysis
Exhibit 39: PAREXEL: Strategy assessment
Exhibit 40: PAREXEL: Opportunity assessment



*** 掲載企業 ***

Bioclinica, Medidata, Oracle, PAREXEL, ArisGlobal, Bio-Optronics, DATATRAK, DSG, ERT Clinical, FORTE, MedNet Solutions, Merge, Trial By Fire Solutions, and Veeva Systems.


*** レポートのキーワード ***

治験管理システム(CTMS)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR15300 )"治験管理システム(CTMS)の世界市場2017-2021" (英文:Global Clinical Trial Management System (CTMS) Market 2017-2021)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。